BackDNA Print Genomics Overview

DNA Print Genomics Accounts Payable

DNA Print Genomics's accounts payable is $2.6M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$2.65M
33.37% YoYΔ $662806.00 vs prior year quarter

Peer average

Loading

DNA Print Genomics Accounts Payable History

Loading

DNA Print Genomics vs. peers: Accounts Payable Comparison

Loading

DNA Print Genomics Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

DNA Print Genomics (DNAG) FAQ

As of the most recent data (September 2007), DNAG shows a accounts payable of $2.6M. That compares with $2M in the prior-year period — up 33.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DNAG's accounts payable is now $2.6M (was $2M) — a 33.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether DNA Print Genomics is outperforming or lagging.

Tracking DNAG's accounts payable over time shows whether DNA Print Genomics is scaling, shrinking, or reshaping that part of the business. The current reading is $2.6M That compares with $2M in the prior-year period — up 33.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has DNA Print Genomics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $2.6M) with ownership activity and broader fundamentals.

DNA Print Genomics's accounts payable is $2.6M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.